NO994793L - Fremgangsmåte for fremstilling av clavulansyre - Google Patents

Fremgangsmåte for fremstilling av clavulansyre

Info

Publication number
NO994793L
NO994793L NO994793A NO994793A NO994793L NO 994793 L NO994793 L NO 994793L NO 994793 A NO994793 A NO 994793A NO 994793 A NO994793 A NO 994793A NO 994793 L NO994793 L NO 994793L
Authority
NO
Norway
Prior art keywords
preparation
clavulanic acid
clavulanic
acid
Prior art date
Application number
NO994793A
Other languages
English (en)
Other versions
NO994793D0 (no
NO325523B1 (no
Inventor
Michael Allen Cook
Mazin Nicola
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706846.4A external-priority patent/GB9706846D0/en
Priority claimed from GBGB9713887.9A external-priority patent/GB9713887D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO994793D0 publication Critical patent/NO994793D0/no
Publication of NO994793L publication Critical patent/NO994793L/no
Publication of NO325523B1 publication Critical patent/NO325523B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
NO19994793A 1997-04-04 1999-10-01 Fremgangsmate for fremstilling av et kaliumsalt av clavulansyre. NO325523B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9706846.4A GB9706846D0 (en) 1997-04-04 1997-04-04 Process
GBGB9713887.9A GB9713887D0 (en) 1997-07-02 1997-07-02 Process
PCT/EP1998/002137 WO1998045300A1 (en) 1997-04-04 1998-04-02 A process for the preparation of a metal salt of clavulanic acid

Publications (3)

Publication Number Publication Date
NO994793D0 NO994793D0 (no) 1999-10-01
NO994793L true NO994793L (no) 1999-10-01
NO325523B1 NO325523B1 (no) 2008-06-02

Family

ID=26311317

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994793A NO325523B1 (no) 1997-04-04 1999-10-01 Fremgangsmate for fremstilling av et kaliumsalt av clavulansyre.

Country Status (26)

Country Link
US (1) US6300495B1 (no)
EP (1) EP0970087B1 (no)
JP (1) JP2001521509A (no)
KR (1) KR100540955B1 (no)
CN (1) CN1258535C (no)
AR (1) AR012307A1 (no)
AU (1) AU736305B2 (no)
BR (1) BR9808467A (no)
CA (1) CA2286369C (no)
CO (1) CO4940460A1 (no)
CZ (1) CZ298785B6 (no)
DE (1) DE69838747T2 (no)
DZ (1) DZ2456A1 (no)
ES (1) ES2294815T3 (no)
HK (1) HK1025098A1 (no)
HU (1) HUP0003621A3 (no)
IL (1) IL132160A (no)
MA (1) MA24519A1 (no)
MY (1) MY120732A (no)
NO (1) NO325523B1 (no)
NZ (1) NZ337998A (no)
PE (1) PE62499A1 (no)
PL (1) PL190943B1 (no)
TR (1) TR199902447T2 (no)
TW (1) TW444016B (no)
WO (1) WO1998045300A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008067440A2 (en) * 2006-11-29 2008-06-05 Dr. Reddy's Laboratories Ltd. Rosuvastatin dehydroabietylamine salt
CN103833774A (zh) * 2014-03-21 2014-06-04 山东新时代药业有限公司 一种从克拉维酸钾混粉中回收有效成分的方法
CN109305978A (zh) * 2017-07-26 2019-02-05 山东睿鹰先锋制药有限公司 一种制备克拉维酸盐的新方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
GB9305565D0 (en) 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes
US5821364A (en) * 1993-03-26 1998-10-13 Gist-Brocades N.V. Diamine salts of clavulanic acid
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
DE69618045D1 (de) * 1995-02-25 2002-01-31 Spurcourt Ltd Clavulansäure Salz
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
NO994793D0 (no) 1999-10-01
EP0970087A1 (en) 2000-01-12
IL132160A (en) 2003-03-12
IL132160A0 (en) 2001-03-19
NZ337998A (en) 2001-05-25
MA24519A1 (fr) 1998-12-31
CN1258535C (zh) 2006-06-07
CA2286369C (en) 2007-11-13
KR100540955B1 (ko) 2006-01-10
DZ2456A1 (fr) 2003-01-18
HUP0003621A3 (en) 2001-09-28
NO325523B1 (no) 2008-06-02
PL190943B1 (pl) 2006-02-28
CA2286369A1 (en) 1998-10-15
PL336040A1 (en) 2000-06-05
DE69838747D1 (de) 2008-01-03
CZ350099A3 (cs) 2000-03-15
HUP0003621A2 (hu) 2001-04-28
JP2001521509A (ja) 2001-11-06
WO1998045300A1 (en) 1998-10-15
MY120732A (en) 2005-11-30
EP0970087B1 (en) 2007-11-21
BR9808467A (pt) 2000-05-23
TW444016B (en) 2001-07-01
CN1258298A (zh) 2000-06-28
PE62499A1 (es) 1999-09-10
HK1025098A1 (en) 2000-11-03
AU736305B2 (en) 2001-07-26
AU7524298A (en) 1998-10-30
DE69838747T2 (de) 2008-09-25
CO4940460A1 (es) 2000-07-24
ES2294815T3 (es) 2008-04-01
AR012307A1 (es) 2000-10-18
US6300495B1 (en) 2001-10-09
CZ298785B6 (cs) 2008-01-30
TR199902447T2 (xx) 2000-01-21
KR20010005967A (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
NO943093D0 (no) Fremgangsmåte for fremstilling av clavulansyre
NO970212D0 (no) Fremgangsmåte for fremstilling av enantiomerene av O-demetyltramadol
NO20002174D0 (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
FI963050A (fi) Menetelmä klavulaanihapposuolan valmistamiseksi
NO993949L (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO993912D0 (no) Fremgangsmåte for fremstilling av eprosartan
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
NO993913D0 (no) Fremgangsmåte for fremstilling av eprosartan
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
NO991672D0 (no) FremgangsmÕte for fremstilling av hydroksaminsyrer
NO985824D0 (no) Forbedret fremgangsmÕte for fremstilling av kalium-clavulanat
NO994793D0 (no) FremgangsmÕte for fremstilling av clavulansyre
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
ZA973139B (en) Process for the preparation of clavulanic acid
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO20001793L (no) FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO995841D0 (no) Fremgangsmåte for fremstilling av 3-(7-amidino-2-naftyl)-2-fenylpropionsyre-derivater
ZA988190B (en) Process for the preparation of 1-phenylpyrazoline-3-carboxylic acid derivatives
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
NO991098D0 (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater
NO982975D0 (no) FremgangsmÕte for fremstilling av fosfatbundne keramer